Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase

被引:48
|
作者
Liu, J
Chakraborty, C
Graham, CH
Barbin, YP
Dixon, SJ
Lala, PK
机构
[1] Univ Western Ontario, Fac Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada
[2] Univ Western Ontario, Dept Pathol, London, ON N6A 5C1, Canada
[3] Univ Western Ontario, Dept Physiol, London, ON N6A 5C1, Canada
[4] Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada
关键词
urokinase-type plasminogen activator; urokinase-type plasminogen activator receptors; migration; extravillous trophoblast; intracellular calcium; phosphatidylinositol; 3-kinase; phospholipase C; mitogen-activated protein kinase;
D O I
10.1016/S0014-4827(03)00089-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The serine protease urokinase-type plasminogen activator (uPA) promotes matrix degradation by many cell types, including the invasive extravillous trophoblast (EVT) of the human placenta. The noncatalytic amino-terminal end of uPA binds to uPA receptors (uPARs) expressed by these cells. A highly polarized expression of uPAR-bound uPA at the migration front of EVT cells in situ suggests a functional role of uPA:uPAR interaction in EVT cell migration. The present study examined whether uPA stimulates EVT cell migration, independent of proteolytic function, and investigated some of the signaling pathways involved. Using in vitro-propagated EVT cells in Transwell migration assays, both uPA and its noncatalytic amino-terminal fragment (ATF) were shown to stimulate migration through multiporous polycarbonate (pore size 8 mum) membranes. A uPAR-blocking antibody inhibited basal and ATF-stimulated migration. Migration was found to be stimulated by hypoxic conditions, which upregulates uPAR expression; this stimulation was abrogated with the uPAR-blocking antibody, indicating the role of endogenous uPA in EVT cell migration. Spectrofluorometric measurement of cytosolic calcium in cells treated with uPA and ATF demonstrated a rapid rise in [Ca2+](i), which was prevented by pretreatment of cells with thapsigargin, indicating a release from intracellular stores. Both basal and ATF-mediated migratory responses were suppressed in the presence of selective pharmacological inhibitors LY294002, U73122, and U0126, implicating the respective roles of phosphatidinylinositol 3-kinase (PI 3-K), phospholipase C (PLC), and MEK1/2 in basal and ATF-stimulated migratory capacity. Taken together, these results demonstrate that uPA:uPAR interaction stimulates EVT cell migration, independent of uPA enzymatic activity, using the mitogen-activated protein kinase pathway and calcium signaling events including the participation of PI 3-K and PLC. These findings are relevant to clinical conditions of aberrant trophoblast migration, including spontaneous abortion, preeclampsia, and choriocarcinoma. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:138 / 151
页数:14
相关论文
共 50 条
  • [21] Activation mitogen-activated protein (MAP) kinase by PDGF-BB is mediated by phosphatidylinositol 3-kinase in normal human osteoblastic cells.
    Chaudhary, LR
    Avioli, LV
    FASEB JOURNAL, 1997, 11 (09): : A1175 - A1175
  • [22] Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils
    Miike, S
    Kurasawa, K
    Saito, Y
    Iwamoto, I
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (01) : 117 - 126
  • [23] Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway
    Hawes, BE
    Luttrell, LM
    vanBiesen, T
    Lefkowitz, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12133 - 12136
  • [24] Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma
    Yamamoto, Takatoshi
    Ohno, Takatoshi
    Wakahara, Kazuhiko
    Nagano, Akihito
    Kawai, Gou
    Saitou, Mitsuru
    Takigami, Iori
    Matsuhashi, Aya
    Yamada, Kazunari
    Shimizu, Katsuji
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (08) : 1125 - 1136
  • [25] Epidermal growth factor stimulation of RPE cell survival: contribution of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways
    Defoe, DM
    Grindstaff, RD
    EXPERIMENTAL EYE RESEARCH, 2004, 79 (01) : 51 - 59
  • [26] Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma
    Takatoshi Yamamoto
    Takatoshi Ohno
    Kazuhiko Wakahara
    Akihito Nagano
    Gou Kawai
    Mitsuru Saitou
    Iori Takigami
    Aya Matsuhashi
    Kazunari Yamada
    Katsuji Shimizu
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1125 - 1136
  • [27] A novel pathway of ceramide signaling through tyrosine kinase, p21ras, phosphatidylinositol 3-kinase and mitogen-activated protein kinase
    Brindley, DN
    Kikuchi, Y
    Chan, E
    Stone, JC
    Hanna, AN
    FASEB JOURNAL, 1998, 12 (08): : A1289 - A1289
  • [28] Midkine inhibits caspase dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons
    Owada, K
    Sanjo, N
    Kobayashi, T
    Mizusawa, H
    Muramatsu, H
    Muramatsu, T
    Michikawa, M
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (05) : 2084 - 2092
  • [29] Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase
    Gaben, AM
    Saucier, C
    Bedin, M
    Redeuilh, G
    Mester, J
    MOLECULAR ENDOCRINOLOGY, 2004, 18 (11) : 2700 - 2713
  • [30] A novel bifunctional phospholipase C that is regulated by Gα12 and stimulates the Ras/mitogen-activated protein kinase pathway
    Lopez, I
    Mak, EC
    Ding, JR
    Hamm, HE
    Lomasney, JW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) : 2758 - 2765